Stereotaxis, Inc. ( STXS) - Key Metrics
STXS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.09 | -$0.06 | -$0.04 | -$0.04 |
| 2025Q3 | $0.08 | -$0.07 | -$0.05 | -$0.05 |
| 2025Q2 | $0.10 | -$0.04 | -$0.04 | -$0.04 |
| 2025Q1 | $0.09 | -$0.07 | -$0.02 | -$0.02 |
STXS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -9.98 |
| 2025Q3 | ? | -11.07 |
| 2025Q2 | ? | -12.17 |
| 2025Q1 | ? | -6.63 |
STXS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -1.94% | ? |
| 2025Q4 | -1.83% | ? |
| 2025Q3 | -1.47% | ? |
| 2025Q2 | -2.02% | ? |
| 2025Q1 | -1.15% | ? |
STXS
Price: $1.90
52 week price:
Earnings Per Share: -0.24 USD
Exchange: ASE
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 50343
Ebitda: -5.0 millionMarket Capitalization: 180.8 million